Srijan Shrestha

Srijan Shrestha

Higher Degree by Research Candidate

Adelaide Medical School

Faculty of Health and Medical Sciences


Srijan Shrestha is studying at The University of Adelaide, Department of Pharmacology (Ph.D.). Srijan completed his Master's degree focusing on the various small molecules that have the potential to become future therapeutics for diabetes and Alzheimer's disease. Their current project is 'Marine-derived phlorotannins and their potential applications". His work in these areas has been published in high-impact-factor and peer-reviewed journals, including ACS, RSC, Elsevier, MDPI, and Springer.

    Expand
  • Journals

    Year Citation
    2021 Shrestha, S., Zhang, W., & Smid, S. D. (2021). Phlorotannins: A review on biosynthesis, chemistry and bioactivity. Food Bioscience, 39, 100832.
    DOI
    2020 Shrestha, S., Zhang, W., Begbie, A. J., Pukala, T. L., & Smid, S. D. (2020). Ecklonia radiata extract containing eckol protects neuronal cells against Aβ1-42 evoked toxicity and reduces aggregate density.. Food Funct, 11(7), 6509-6516.
    DOI Scopus1 WoS1
    2020 Ha, M. T., Shrestha, S., Tran, T. H., Kim, J. A., Woo, M. H., Choi, J. S., & Min, B. S. (2020). Inhibition of PTP1B by farnesylated 2-arylbenzofurans isolated from Morus alba root bark: unraveling the mechanism of inhibition based on in vitro and in silico studies. Archives of Pharmacal Research, 43(9), 961-975.
    DOI
    2020 Paudel, P., Shrestha, S., Park, S. E., Seong, S. H., Fauzi, F. M., Jung, H. A., & Choi, J. S. (2020). Emodin derivatives as multi-target-directed ligands inhibiting monoamine oxidase and antagonizing vasopressin V<inf>1A</inf>receptors. ACS Omega, 5(41), 26720-26731.
    DOI
    2019 Shrestha, S., Seong, S. H., Park, S. G., Min, B. S., Jung, H. A., & Choi, J. S. (2019). Insight into the PTP1B inhibitory activity of arylbenzofurans: An in vitro and in silico study. Molecules, 24(16), 11 pages.
    DOI Scopus4 WoS3
    2019 Yang, S. J., Paudel, P., Shrestha, S., Seong, S. H., Jung, H. A., & Choi, J. S. (2019). In vitro protein tyrosine phosphatase 1B inhibition and antioxidant property of different onion peel cultivars: A comparative study. Food Science and Nutrition, 7(1), 205-215.
    DOI WoS1
    2019 Paudel, P., Seong, S. H., Shrestha, S., Jung, H. A., & Choi, J. S. (2019). In Vitro and in Silico Human Monoamine Oxidase Inhibitory Potential of Anthraquinones, Naphthopyrones, and Naphthalenic Lactones from Cassia obtusifolia Linn Seeds. ACS Omega, 4(14), 16139-16152.
    DOI Scopus8 WoS8 Europe PMC3
    2019 Wagle, A., Seong, S. H., Shrestha, S., Ah Jung, H., & Choi, J. S. (2019). Korean thistle (cirsium japonicum var. Maackii (Maxim.) Matsum.): A potential dietary supplement against diabetes and Alzheimer’s disease. Molecules, 24(3), 649.
    DOI Scopus3 Europe PMC1
    2018 Koirala, P., Seong, S. H., Zhou, Y., Shrestha, S., Jung, H. A., & Choi, J. S. (2018). Structure–Activity relationship of the tyrosinase inhibitors kuwanon G, mulberrofuran G, and albanol B from morus species: A kinetics and molecular docking Study. Molecules, 23(6), 1413.
    DOI Scopus10 Europe PMC4
    2018 Ha, M. T., Park, D. H., Shrestha, S., Kim, M., Kim, J. A., Woo, M. H., . . . Min, B. S. (2018). PTP1B inhibitory activity and molecular docking analysis of stilbene derivatives from the rhizomes of Rheum undulatum L.. Fitoterapia, 131, 119-126.
    DOI Scopus8 Europe PMC1
    2018 Shrestha, S., Paudel, P., Seong, S. H., Min, B. S., Seo, E. K., Jung, H. A., & Choi, J. S. (2018). Two new naphthalenic lactone glycosides from Cassia obtusifolia L. seeds. Archives of Pharmacal Research, 41(7), 737-742.
    DOI Scopus6 Europe PMC4
    2018 Shrestha, S., Seong, S. H., Paudel, P., Jung, H. A., & Choi, J. S. (2018). Structure related inhibition of enzyme systems in cholinesterases and BACE1 in vitro by naturally occurring naphthopyrone and its glycosides isolated from cassia obtusifolia. Molecules, 23(1), 69.
    DOI Scopus11 Europe PMC7

Connect With Me
External Profiles